BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36698130)

  • 1. Retraction Note: ANGPTL4 functions as an oncogene through regulation of the ETV5/CDH5/AKT/MMP9 axis to promote angiogenesis in ovarian cancer.
    Liu Y; Yang R; Zhang Y; Zhu Y; Bao W
    J Ovarian Res; 2023 Jan; 16(1):23. PubMed ID: 36698130
    [No Abstract]   [Full Text] [Related]  

  • 2. ANGPTL4 functions as an oncogene through regulation of the ETV5/CDH5/AKT/MMP9 axis to promote angiogenesis in ovarian cancer.
    Liu Y; Yang R; Zhang Y; Zhu Y; Bao W
    J Ovarian Res; 2022 Dec; 15(1):131. PubMed ID: 36517864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.
    Llauradó M; Abal M; Castellví J; Cabrera S; Gil-Moreno A; Pérez-Benavente A; Colás E; Doll A; Dolcet X; Matias-Guiu X; Vazquez-Levin M; Reventós J; Ruiz A
    Int J Cancer; 2012 Apr; 130(7):1532-43. PubMed ID: 21520040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulation of angiopoietin-like 4 slows ovarian cancer progression through vascular endothelial growth factor receptor 2 phosphorylation.
    Wu Y; Gao J; Liu X
    Cancer Cell Int; 2021 Mar; 21(1):171. PubMed ID: 33726754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet-derived growth factor BB.
    Cheng X; Jin Z; Ji X; Shen X; Feng H; Morgenlander W; Ou B; Wu H; Gao H; Ye F; Zhang Y; Peng Y; Liang J; Jiang Y; Zhang T; Qiu W; Lu X; Zhao R
    Int J Cancer; 2019 Jul; 145(1):179-191. PubMed ID: 30650178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5
    Feng H; Liu K; Shen X; Liang J; Wang C; Qiu W; Cheng X; Zhao R
    Cell Death Dis; 2020 Oct; 11(10):916. PubMed ID: 33099574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal Growth Factor Receptor Mutation Enhances Expression of Cadherin-5 in Lung Cancer Cells.
    Hung MS; Chen IC; Lung JH; Lin PY; Li YC; Tsai YH
    PLoS One; 2016; 11(6):e0158395. PubMed ID: 27362942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of gene expression regulated by the ETV5 transcription factor in OV90 ovarian cancer cells identifies FOXM1 overexpression in ovarian cancer.
    Llauradó M; Majem B; Castellví J; Cabrera S; Gil-Moreno A; Reventós J; Ruiz A
    Mol Cancer Res; 2012 Jul; 10(7):914-24. PubMed ID: 22589409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
    Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
    J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA CCAL Promotes Angiogenesis Through Regulating the MiR-29b/ANGPTL4 Axis in Osteosarcoma.
    Chen S; Yang M; Chang S
    Cancer Manag Res; 2020; 12():10521-10530. PubMed ID: 33122950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDL-apoA-I induces the expression of angiopoietin like 4 (ANGPTL4) in endothelial cells via a PI3K/AKT/FOXO1 signaling pathway.
    Theofilatos D; Fotakis P; Valanti E; Sanoudou D; Zannis V; Kardassis D
    Metabolism; 2018 Oct; 87():36-47. PubMed ID: 29928895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oncogene Etv5 promotes MET in somatic reprogramming and orchestrates epiblast/primitive endoderm specification during mESCs differentiation.
    Zhang J; Cao H; Xie J; Fan C; Xie Y; He X; Liao M; Zhang S; Wang H
    Cell Death Dis; 2018 Feb; 9(2):224. PubMed ID: 29445086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAZ Regulates the Cisplatin Resistance of Epithelial Ovarian Cancer Cells via the ANGPTL4/SOX2 Axis.
    Li C; Wang Q; Luo Y; Xiang J
    Anal Cell Pathol (Amst); 2022; 2022():5632164. PubMed ID: 36247876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer.
    Larsson P; Syed Khaja AS; Semenas J; Wang T; Sarwar M; Dizeyi N; Simoulis A; Hedblom A; Wai SN; Ødum N; Persson JL
    Int J Cancer; 2020 Mar; 146(6):1686-1699. PubMed ID: 31381135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma.
    Katanasaka Y; Kodera Y; Kitamura Y; Morimoto T; Tamura T; Koizumi F
    Mol Cancer; 2013 Apr; 12():31. PubMed ID: 23617883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estradiol-ERβ2 signaling axis confers growth and migration of CRPC cells through TMPRSS2-ETV5 gene fusion.
    Kim H; Datta A; Talwar S; Saleem SN; Mondal D; Abdel-Mageed AB
    Oncotarget; 2017 Sep; 8(38):62820-62833. PubMed ID: 28968951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-type 12-lipoxygenase induces MMP9 expression and cellular invasion via activation of PI3K/Akt/NF-κB.
    Dilly AK; Ekambaram P; Guo Y; Cai Y; Tucker SC; Fridman R; Kandouz M; Honn KV
    Int J Cancer; 2013 Oct; 133(8):1784-91. PubMed ID: 23526143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.
    Hsieh HY; Jou YC; Tung CL; Tsai YS; Wang YH; Chi CL; Lin RI; Hung SK; Chuang YM; Wu SF; Li C; Shen CH; Chan MWY; Hsu CD
    Oncogene; 2018 Feb; 37(5):673-686. PubMed ID: 29035390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Angptl4 in vascular permeability and inflammation.
    Guo L; Li SY; Ji FY; Zhao YF; Zhong Y; Lv XJ; Wu XL; Qian GS
    Inflamm Res; 2014 Jan; 63(1):13-22. PubMed ID: 24173241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oleic acid-induced NOX4 is dependent on ANGPTL4 expression to promote human colorectal cancer metastasis.
    Shen CJ; Chang KY; Lin BW; Lin WT; Su CM; Tsai JP; Liao YH; Hung LY; Chang WC; Chen BK
    Theranostics; 2020; 10(16):7083-7099. PubMed ID: 32641980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.